Article(id=1330232880195809840, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330232866111336883, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.08.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1676563200000, receivedDateStr=2023-02-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795081833170, onlineDateStr=2026-11-19, pubDate=1691596800000, pubDateStr=2023-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795081833170, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795081833170, creator=13701087609, updateTime=1795081833170, updator=13701087609, issue=Issue{id=1330232866111336883, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='8', pageStart='1145', pageEnd='1282', issueExtLink='null', onlineDate='null', pubDate='1691596800000', pubDateStr='2023-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795081829811, creator='13701087609', updateTime=1795082517499, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330235751737962511, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330232866111336883, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330235751737962512, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330232866111336883, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1145, endPage=1156, ext={EN=ArticleExt(id=1330232880413913649, articleId=1330232880195809840, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Progress in the Synthesis of Ozanimod Hydrochloride, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Ozanimod hydrochloride, a new type of oral sphingosine 1-phosphate(S1P) receptor modulator, is clinically used for the treatment of relapsing multiple sclerosis. In this review, the synthetic methods of ozanimod hydrochloride and its key intermediates are summarized and evaluated based on different schemes described in the literature. The scaffold structure of ozanimod hydrochloride is (S)-1-amino-4-(1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-indene. Starting from 4-cyano-2,3-dihydro-1H-inden-1-one(2), chiral auxiliary agents or catalysts for asymmetric hydrogenation are used to construct the chiral amino group at the 1-position of 2,3-dihydro-1H-indene. Alternatively, the 1-carbonyl group is converted to the chiral hydroxyl before constructing the chiral amino group. The oxadiazole ring at the 4-position of 2,3-dihydro-1H-indene is synthesized in situ from 4-cyano group.

, authors=Junzheng WANG1, Dongmei WANG1, Tianming YANG2, *, authorsList=Junzheng WANG, Dongmei WANG, Tianming YANG, authorCompany=null, correspAuthors=Tianming YANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330232880946590262, articleId=1330232880195809840, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=盐酸奥扎莫德的合成研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

盐酸奥扎莫德是一种新型口服1-磷酸鞘氨醇(S1P)受体调节剂,临床上用于治疗复发性多发性硬化。文章根据不同的合成思路对盐酸奥扎莫德及其重要中间体的合成方法进行总结和概括,并对各路线进行了简要评价。盐酸奥扎莫德骨架结构是(S)-1-氨基-4-(1,2,4-二唑-3-基)-2,3-二氢-1H-茚。以4-氰基-2,3-二氢-1H-1-茚酮(2)为原料,应用手性辅助剂或不对称氢化催化剂,在2,3-二氢-1H-1-茚的1-位构建手性氨基;或者先将1-位羰基转换为手性羟基,再合成手性氨基。在2,3-二氢-1H-1-茚的4-位,原位合成二唑环。

, authors=王军政1, 王冬梅1, 杨天明2, *, authorsList=王军政, 王冬梅, 杨天明, authorCompany=null, correspAuthors=杨天明, authorNote=

王军政(1998—),男,硕士研究生,专业方向:药物化学。

, correspAuthorsNote=
杨天明(1977—),男,博士,副研究员,从事创新药的研究工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=H3ztLZN+iD4gImGCoCBvRw==, magXml=Deyw5/y+t33itovqFDiibw==, pdfUrl=null, pdf=JnDsnwiByXU5fvtpX3Nv/A==, pdfFileSize=2270905, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ICsMY2IWffi96wiIPDBaaw==, mapNumber=null, fund=null)}, authors=[Author(id=1330232882896941630, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330232882976633408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232882896941630, language=EN, stringName=Junzheng WANG, firstName=Junzheng, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883043742273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232882896941630, language=CN, stringName=王军政, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110, bio={"content":"

王军政(1998—),男,硕士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

王军政(1998—),男,硕士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882720780855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=1., ext=[AuthorCompanyExt(id=1330232882729169464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110), AuthorCompanyExt(id=1330232882737558073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110)])]), Author(id=1330232883110851139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330232883186348613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883110851139, language=EN, stringName=Dongmei WANG, firstName=Dongmei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883257651782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883110851139, language=CN, stringName=王冬梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882720780855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=1., ext=[AuthorCompanyExt(id=1330232882729169464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110), AuthorCompanyExt(id=1330232882737558073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110)])]), Author(id=1330232883316372040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yangtm@tipr.com.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330232883391869514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883316372040, language=EN, stringName=Tianming YANG, firstName=Tianming, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883467366987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883316372040, language=CN, stringName=杨天明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882821444154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=2., ext=[AuthorCompanyExt(id=1330232882834027067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301), AuthorCompanyExt(id=1330232882842415676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301)])])], keywords=[Keyword(id=1330232883584807500, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=EN, orderNo=1, keyword=ozanimod hydrochloride), Keyword(id=1330232883656110669, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=EN, orderNo=2, keyword=sphingosine 1-phosphate receptor modulator), Keyword(id=1330232883731608142, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=EN, orderNo=3, keyword=synthesis), Keyword(id=1330232883798717007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=EN, orderNo=4, keyword=multiple sclerosis), Keyword(id=1330232883895186000, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=CN, orderNo=1, keyword=盐酸奥扎莫德), Keyword(id=1330232883983266385, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=CN, orderNo=2, keyword=1-磷酸鞘氨醇受体调节剂), Keyword(id=1330232884046180946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=CN, orderNo=3, keyword=合成), Keyword(id=1330232884109095507, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, language=CN, orderNo=4, keyword=多发性硬化)], refs=[Reference(id=1330232884201370196, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=马宏智,孙铁民.盐酸奥扎莫德(Ozanimod hydrochloride,Zeposia)[J].中国药物化学杂志,2021,31(3):247., articleTitle=null, refAbstract=null), Reference(id=1330232884260090453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=LAMB Y N. Ozanimod: first approval [J]. Drugs, 2020,80(8): 841-848., articleTitle=null, refAbstract=null), Reference(id=1330232884335587926, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=张建忠.2020年3—4月FDA批准新药概况[J].上海医药,2020,41(13):80-81., articleTitle=null, refAbstract=null), Reference(id=1330232884402696791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=ROBERTS E, ROSEN H, BROWN S, et al. Novel modulators of sphingosine phosphate receptors: WO,2009151529A1 [P]. 2009-12-17., articleTitle=null, refAbstract=null), Reference(id=1330232884473999960, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=MARTINBOROUGH E, BOEHM M F, YEAGER A R, et al. Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis: WO, 2011060392A1 [P]. 2011-05-19., articleTitle=null, refAbstract=null), Reference(id=1330232884545303129, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG Q, SHENG M, HENKELIS J J, et al. Explosion hazards of sodium hydride in dimethyl sulfoxide, N, N-dimethylformamide, and N, N-dimethylac [J]. Org Process Res Dev, 2019, 23(10): 2210-2217., articleTitle=null, refAbstract=null), Reference(id=1330232884604023386, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCABE DUNN J M, DURAN-CAPECE A, MEEHAN B, et al. The safe use of sodium hydride on scale: the process development of a chloropyrimidine displacement [J]. Org Process Res Dev, 2011, 15(6): 1442-1446., articleTitle=null, refAbstract=null), Reference(id=1330232884654355035, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=PORCS-MAKKAY M, SIMIG G, MOLNAR E, et al. Process for the production of ozanimod: WO, 2018215807A1[P]. 2018-11-29., articleTitle=null, refAbstract=null), Reference(id=1330232884738241116, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=许国彬,胡燕青,王仲清,等.奥扎莫德及其中间体的制备方法:中国,112062785A [P].2020-12-11., articleTitle=null, refAbstract=null), Reference(id=1330232884822127197, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=张席妮,周涛,熊志刚,等.奥扎莫德及其中间体的制备方法:中国,108727291A [P].2018-11-02., articleTitle=null, refAbstract=null), Reference(id=1330232884926984798, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAKILAM N, ACHAMPETA K R, REBELLI P, et al. An improved process for the preparation of ozanimod and intermediates thereof: IN, 202041008153A [P]. 2020-02-26., articleTitle=null, refAbstract=null), Reference(id=1330232885010870879, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=BUCHLOVIC M, CHALUPOVA L, VYKLICKY L, et al. Improved process for preparing ozanimod: WO,2020115200A1 [P]. 2020-06-11., articleTitle=null, refAbstract=null), Reference(id=1330232885086368352, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KAUSHIK V K, MULAMALLA R R, SRIDHAR T, et al. A process for the preparation of ozanimod or its pharmaceutically acceptable salts: IN, 202141007085A[P]. 2021-02-19., articleTitle=null, refAbstract=null), Reference(id=1330232885145088609, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRECA G, CARCONE L, TADDEI M, et al. Process for the preparation of ozanimod as sphingosine-1-phosphate receptor agonist: WO, 2020064818A1 [P]. 2020-04-02., articleTitle=null, refAbstract=null), Reference(id=1330232885212197474, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=CIANFEROTTI C, BARRECA G, BOLLABATHINI V, et al. Enantioselective synthesis of ozanimod, the active pharmaceutical ingredient of a new drug for multiple sclerosis [J]. Eur J Org Chem, 2021, 2021(12): 1924-1930., articleTitle=null, refAbstract=null), Reference(id=1330232885296083555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAR S, AHMAD G, BHAVSAR J, et al. Compounds and their use in preparation of ozanimod and salts thereof:IN, 201911046561A [P]. 2019-11-15., articleTitle=null, refAbstract=null), Reference(id=1330232885384163940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=苏伟,许国彬,孙国栋,等.一种茚满酮中间体的制备方法:中国,110627683A [P].2019-12-31., articleTitle=null, refAbstract=null), Reference(id=1330232885447078501, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=曾海峰.3-(2-氰基苯基)丙酸及4-氰基-1-茚满酮的制备方法:中国,113214111A [P].2021-08-06., articleTitle=null, refAbstract=null), Reference(id=1330232887057691238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG C, CHAKMA J. Deuterium-substituted oxadiazoles: WO, 2016164180A1 [P]. 2016-10-13., articleTitle=null, refAbstract=null), Reference(id=1330232887137383015, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=黄轩.一种制备4-氰基-1-茚酮的方法:中国,110003049A[P].2019-07-12., articleTitle=null, refAbstract=null), Reference(id=1330232887267406440, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=随裕敏,戢颖瑶,郭东方,等.一种ozanimod中间体4-氰基茚酮的合成方法:中国,110128292A [P].2019-08-16., articleTitle=null, refAbstract=null), Reference(id=1330232887334515305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BAILEY J, KING N P, LIN X, et al. Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1(S1P1) receptor agonists: WO, 2011072488A1 [P]. 2011-06-23., articleTitle=null, refAbstract=null), Reference(id=1330232887397429866, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=JONES R M, BUZARD D J, HAN S, et al. Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders: WO, 2011005290A1 [P]. 2011-01-13., articleTitle=null, refAbstract=null), Reference(id=1330232887460344427, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=XU W. Oxadiazole modulators of S1P methods of making and using: WO, 2017004608A1 [P]. 2017-01-05., articleTitle=null, refAbstract=null), Reference(id=1330232887544230508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=池永贵,黄轩.一种制备3-氰基-4-异丙氧基苯甲酸的方法:中国,106674047A [P].2017-05-17., articleTitle=null, refAbstract=null), Reference(id=1330232887607145069, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSEN T V, SKATTEBØL L. Ortho-formylation of phenols; preparation of 3-bromosalicylaldehyde [J]. Org Synth, 2005, 82: 64-68., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330232882720780855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=1., ext=[AuthorCompanyExt(id=1330232882729169464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110), AuthorCompanyExt(id=1330232882737558073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110)]), AuthorCompany(id=1330232882821444154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=2., ext=[AuthorCompanyExt(id=1330232882834027067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301), AuthorCompanyExt(id=1330232882842415676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.08.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.08.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.08.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.08.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1691596800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
盐酸奥扎莫德的合成研究进展
王军政 1 , 王冬梅 1 , 杨天明 2, *
中国医药工业杂志 | 综述 2023,54(8): 1145-1156
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (8) : 1145 -1156
盐酸奥扎莫德的合成研究进展
全屏
[Author(id=1330232882896941630, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330232882976633408, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232882896941630, language=EN, stringName=Junzheng WANG, firstName=Junzheng, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883043742273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232882896941630, language=CN, stringName=王军政, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110, bio={"content":"

王军政(1998—),男,硕士研究生,专业方向:药物化学。

"}, bioImg=null, bioContent=

王军政(1998—),男,硕士研究生,专业方向:药物化学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882720780855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=1., ext=[AuthorCompanyExt(id=1330232882729169464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110), AuthorCompanyExt(id=1330232882737558073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110)])]), Author(id=1330232883110851139, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330232883186348613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883110851139, language=EN, stringName=Dongmei WANG, firstName=Dongmei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883257651782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883110851139, language=CN, stringName=王冬梅, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882720780855, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=1., ext=[AuthorCompanyExt(id=1330232882729169464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110), AuthorCompanyExt(id=1330232882737558073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882720780855, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110)])]), Author(id=1330232883316372040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=yangtm@tipr.com.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330232883391869514, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883316372040, language=EN, stringName=Tianming YANG, firstName=Tianming, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330232883467366987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, authorId=1330232883316372040, language=CN, stringName=杨天明, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330232882821444154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, xref=2., ext=[AuthorCompanyExt(id=1330232882834027067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301), AuthorCompanyExt(id=1330232882842415676, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330232880195809840, companyId=1330232882821444154, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301)])])]
王军政1, 王冬梅1, 杨天明2, *
作者信息
  • 1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110
  • 2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301
通讯作者:
杨天明(1977—),男,博士,副研究员,从事创新药的研究工作。E-mail:
作者简介:

王军政(1998—),男,硕士研究生,专业方向:药物化学。

Progress in the Synthesis of Ozanimod Hydrochloride
Junzheng WANG1, Dongmei WANG1, Tianming YANG2, *
Affiliations
  • 1.College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110
  • 2.Tianjin Key Lab. of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300301
出版时间: 2023-08-10 doi: 10.16522/j.cnki.cjph.2023.08.001
文章导航
收藏切换

盐酸奥扎莫德是一种新型口服1-磷酸鞘氨醇(S1P)受体调节剂,临床上用于治疗复发性多发性硬化。文章根据不同的合成思路对盐酸奥扎莫德及其重要中间体的合成方法进行总结和概括,并对各路线进行了简要评价。盐酸奥扎莫德骨架结构是(S)-1-氨基-4-(1,2,4-二唑-3-基)-2,3-二氢-1H-茚。以4-氰基-2,3-二氢-1H-1-茚酮(2)为原料,应用手性辅助剂或不对称氢化催化剂,在2,3-二氢-1H-1-茚的1-位构建手性氨基;或者先将1-位羰基转换为手性羟基,再合成手性氨基。在2,3-二氢-1H-1-茚的4-位,原位合成二唑环。

盐酸奥扎莫德  /  1-磷酸鞘氨醇受体调节剂  /  合成  /  多发性硬化

Ozanimod hydrochloride, a new type of oral sphingosine 1-phosphate(S1P) receptor modulator, is clinically used for the treatment of relapsing multiple sclerosis. In this review, the synthetic methods of ozanimod hydrochloride and its key intermediates are summarized and evaluated based on different schemes described in the literature. The scaffold structure of ozanimod hydrochloride is (S)-1-amino-4-(1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-indene. Starting from 4-cyano-2,3-dihydro-1H-inden-1-one(2), chiral auxiliary agents or catalysts for asymmetric hydrogenation are used to construct the chiral amino group at the 1-position of 2,3-dihydro-1H-indene. Alternatively, the 1-carbonyl group is converted to the chiral hydroxyl before constructing the chiral amino group. The oxadiazole ring at the 4-position of 2,3-dihydro-1H-indene is synthesized in situ from 4-cyano group.

ozanimod hydrochloride  /  sphingosine 1-phosphate receptor modulator  /  synthesis  /  multiple sclerosis
王军政, 王冬梅, 杨天明. 盐酸奥扎莫德的合成研究进展. 中国医药工业杂志, 2023 , 54 (8) : 1145 -1156 . DOI: 10.16522/j.cnki.cjph.2023.08.001
Junzheng WANG, Dongmei WANG, Tianming YANG. Progress in the Synthesis of Ozanimod Hydrochloride[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (8) : 1145 -1156 . DOI: 10.16522/j.cnki.cjph.2023.08.001

参考文献 引证文献
排序方式:
[1]
马宏智,孙铁民.盐酸奥扎莫德(Ozanimod hydrochloride,Zeposia)[J].中国药物化学杂志,2021,31(3):247.
[2]
LAMB Y N. Ozanimod: first approval [J]. Drugs, 2020,80(8): 841-848.
[3]
张建忠.2020年3—4月FDA批准新药概况[J].上海医药,2020,41(13):80-81.
[4]
ROBERTS E, ROSEN H, BROWN S, et al. Novel modulators of sphingosine phosphate receptors: WO,2009151529A1 [P]. 2009-12-17.
[5]
MARTINBOROUGH E, BOEHM M F, YEAGER A R, et al. Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis: WO, 2011060392A1 [P]. 2011-05-19.
[6]
YANG Q, SHENG M, HENKELIS J J, et al. Explosion hazards of sodium hydride in dimethyl sulfoxide, N, N-dimethylformamide, and N, N-dimethylac [J]. Org Process Res Dev, 2019, 23(10): 2210-2217.
[7]
MCCABE DUNN J M, DURAN-CAPECE A, MEEHAN B, et al. The safe use of sodium hydride on scale: the process development of a chloropyrimidine displacement [J]. Org Process Res Dev, 2011, 15(6): 1442-1446.
[8]
PORCS-MAKKAY M, SIMIG G, MOLNAR E, et al. Process for the production of ozanimod: WO, 2018215807A1[P]. 2018-11-29.
[9]
许国彬,胡燕青,王仲清,等.奥扎莫德及其中间体的制备方法:中国,112062785A [P].2020-12-11.
[10]
张席妮,周涛,熊志刚,等.奥扎莫德及其中间体的制备方法:中国,108727291A [P].2018-11-02.
[11]
CHAKILAM N, ACHAMPETA K R, REBELLI P, et al. An improved process for the preparation of ozanimod and intermediates thereof: IN, 202041008153A [P]. 2020-02-26.
[12]
BUCHLOVIC M, CHALUPOVA L, VYKLICKY L, et al. Improved process for preparing ozanimod: WO,2020115200A1 [P]. 2020-06-11.
[13]
KAUSHIK V K, MULAMALLA R R, SRIDHAR T, et al. A process for the preparation of ozanimod or its pharmaceutically acceptable salts: IN, 202141007085A[P]. 2021-02-19.
[14]
BARRECA G, CARCONE L, TADDEI M, et al. Process for the preparation of ozanimod as sphingosine-1-phosphate receptor agonist: WO, 2020064818A1 [P]. 2020-04-02.
[15]
CIANFEROTTI C, BARRECA G, BOLLABATHINI V, et al. Enantioselective synthesis of ozanimod, the active pharmaceutical ingredient of a new drug for multiple sclerosis [J]. Eur J Org Chem, 2021, 2021(12): 1924-1930.
[16]
KUMAR S, AHMAD G, BHAVSAR J, et al. Compounds and their use in preparation of ozanimod and salts thereof:IN, 201911046561A [P]. 2019-11-15.
[17]
苏伟,许国彬,孙国栋,等.一种茚满酮中间体的制备方法:中国,110627683A [P].2019-12-31.
[18]
曾海峰.3-(2-氰基苯基)丙酸及4-氰基-1-茚满酮的制备方法:中国,113214111A [P].2021-08-06.
[19]
ZHANG C, CHAKMA J. Deuterium-substituted oxadiazoles: WO, 2016164180A1 [P]. 2016-10-13.
[20]
黄轩.一种制备4-氰基-1-茚酮的方法:中国,110003049A[P].2019-07-12.
[21]
随裕敏,戢颖瑶,郭东方,等.一种ozanimod中间体4-氰基茚酮的合成方法:中国,110128292A [P].2019-08-16.
[22]
BAILEY J, KING N P, LIN X, et al. Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1(S1P1) receptor agonists: WO, 2011072488A1 [P]. 2011-06-23.
[23]
JONES R M, BUZARD D J, HAN S, et al. Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders: WO, 2011005290A1 [P]. 2011-01-13.
[24]
XU W. Oxadiazole modulators of S1P methods of making and using: WO, 2017004608A1 [P]. 2017-01-05.
[25]
池永贵,黄轩.一种制备3-氰基-4-异丙氧基苯甲酸的方法:中国,106674047A [P].2017-05-17.
[26]
HANSEN T V, SKATTEBØL L. Ortho-formylation of phenols; preparation of 3-bromosalicylaldehyde [J]. Org Synth, 2005, 82: 64-68.
2023年第54卷第8期
17
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.08.001
  • 接收时间:2023-02-17
  • 首发时间:2026-11-19
  • 出版时间:2023-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-02-17
基金
作者信息
    1.内蒙古医科大学药学院,内蒙古 呼和浩特 010110
    2.天津药物研究院天津市新药设计与发现重点实验室,天津 300301

通讯作者:

杨天明(1977—),男,博士,副研究员,从事创新药的研究工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.08.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏